Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 6,120 shares at $601.70 ($3.7M) on 2020-07-01, disclosed to the SEC on 2020-07-02.
Open-market sale of $3.7M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $601.70 | 100 | $60K | 1.6% |
| 2 | $601.70 | 100 | $60K | 1.6% |
| 3 | $603.39 | 627 | $378K | 10.2% |
| 4 | $603.39 | 627 | $378K | 10.2% |
| 5 | $604.82 | 960 | $581K | 15.6% |
| 6 | $604.82 | 960 |
| $581K |
| 15.6% |
| 7 | $605.78 | 401 | $243K | 6.5% |
| 8 | $605.78 | 401 | $243K | 6.5% |
| 9 | $607.35 | 200 | $121K | 3.3% |
| 10 | $608.59 | 319 | $194K | 5.2% |
| 11 | $608.59 | 319 | $194K | 5.2% |
| 12 | $609.51 | 200 | $122K | 3.3% |
| 13 | $612.29 | 400 | $245K | 6.6% |
| 14 | $615.23 | 100 | $62K | 1.7% |
| 15 | $616.49 | 200 | $123K | 3.3% |
| 16 | $623.07 | 100 | $62K | 1.7% |
| 17 | $623.07 | 100 | $62K | 1.7% |
| 18 | $624.19 | 6 | $4K | 0.1% |
| Total | $606.83 avg | 6,120 | $3.7M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |